Date:24/05/2008 URL: http://www.thehindu.com/2008/05/24/stories/2008052455021500.htm

Business

Strides Arcolab gets ANDA nod for TB drug

MUMBAI: Strides Arcolab on Friday said it had received Abbreviated New Drug Application (ANDA) approval for its Rifampicin injection in the strengths of 600 mg/vial used in the treatment of tuberculosis. The product is licensed to Akorn-Strides LLC.